Article Details

73% CNS ORR! FDA Granted ODD to Utidelone Injectable (UTD1) from Biostar Pharma for ...

Retrieved on: 2024-03-30 00:42:03

Tags for this article:

Click the tags to see associated articles and topics

73% CNS ORR! FDA Granted ODD to Utidelone Injectable (UTD1) from Biostar Pharma for .... View article details on hiswai:

Excerpt

... biopharma company focusing on the development and commercialization of innovative oncology drugs, announced today that their core pipeline product ...

Article found on: fox40.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo